Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.06 by 221.82 percent. This is a 77 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $150.587 million which beat the analyst consensus estimate of $134.100 million by 12.29 percent. This is a 30.74 percent increase over sales of $115.177 million the same period last year.